The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Comorbidities predict overall survival (OS) in men with metastatic castrate-resistant prostate cancer (CRPC).
Susan Halabi
No relevant relationships to disclose
William Kevin Kelly
No relevant relationships to disclose
Daniel J. George
No relevant relationships to disclose
Michael J. Morris
No relevant relationships to disclose
Ellen B Kaplan
No relevant relationships to disclose
Eric Jay Small
No relevant relationships to disclose